The epidemiology of influenza vaccination: Implications for global vaccine supply for an influenza pandemic

International Congress Series

Volumn 1219, Issue C, 2001, Pages 723-731

  Fedson, David S ^a  

^a SANOFI PASTEUR   (France)

Author keywords

Influenza; Pandemic; Vaccination

Indexed keywords

EID: 0012016115     PISSN: 05315131     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0531-5131(01)00657-4     Document Type: Article

References (23)

1. Monto, A.S., Individual and community impact of influenza. Pharmacoeconomics 16:Suppl. 1 (1999), 1–6.
2. Fedson, D.S., Hannoun, C., Leese, J., et al. Influenza vaccination in 18 developed countries, 1981–1992. Vaccine 13 (1995), 623–627.
3. Fedson, D.S., Hirota, Y., Shin, H.K., et al. Influenza vaccination in 22 developed countries; an update to 1995. Vaccine 15 (1997), 1506–1511.
4. Ambrosch, F., Fedson, D.S., Influenza vaccination in 29 countries. An update to 1997. Pharmacoeconomics 16:Suppl. 1 (1999), 47–54.
5. Ambrosch, F., Fedson, D.S., Epidemiology of influenza vaccine distribution (abstract). Options for the Control of Influenza IV, September 23–28, 2000, 126.
6. World Health Organization. Influenza Pandemic Preparedness Plan, April 1999, World Health Organization, Geneva.
7. Monto, A.S., (eds.) Pandemic Influenza: Confronting A Re-Emergent Threat J. Infect. Dis., vol. 176, 1997, S1–S90 Suppl. 1.
8. Dowdle, W.R., The 1976 experience. J. Infect. Dis. 176:Suppl. 1 (1997), S69–S72.
9. Fidler, D.P., Globalization, international law, and emerging infectious diseases. Emerging Infect. Dis. 2 (1996), 77–84.
10. Yach, D., Bettcher, D., The globalization of public health: I. Threats and opportunities. Am. J. Public Health 88 (1998), 735–738.
11. Yach, D., Bettcher, D., The globalization of public health: II. The convergence of self-interest and altruism. Am. J. Public Health 88 (1998), 738–741.
12. Chen, L.C., Evans, T.G., Cash, R.A., Health as a global public good. Kaul, I., Grunberg, M.A., (eds.) Global Public Goods, 1999, Oxford University Press, New York, 284–304.
13. Kaul, I., Grundberg, I., Stern, M.A., Defining global public goods. Kaul, I., Grunberg, M.A., (eds.) Global Public Goods, 1999, Oxford University Press, New York, 2–19.
14. Taylor, A.L., Bettcher, D.W., WHO Framework Convention on Tobacco Control: a global “good” for public health. Bull. W. H. O. 78 (2000), 920–929.
15. O'Brien, E., The diplomatic implications of emerging diseases. Cahill, K.M., (eds.) Preventive Diplomacy, 1996, Basic Books, New York, 244–268.
16. Alleyne, G., Health and national security. Bull. Pan. Am. Health Org. 30 (1996), 158–163.
17. Fidler, D.P., International Law and Infectious Diseases, 1999, Oxford University Press, New York.
18. Reichert, T.A., Fedson, D.S., Glezen, W.P., Sugaya, N., Tashiro, M., Measuring the effect of influenza vaccination programs. The Japanese experience revisited (abstract). Options Control Influenza IV, September 23–28, 2000, 60.
19. Siscovick, D.S., Raghunathan, T.E., Lin, D., et al. Influenza vaccination and the risk of primary cardiac arrest. Am. J. Epidemiol. 152 (2000), 674–677.
20. World Health Organization. Influenza vaccine. Wkly. Epidemiol. Rec. 35 (2000), 281–288.
21. Snaken, R., Kendal, A.P., Haaheim, L., Wood, J.M., The next influenza pandemic: lessons from Hong Kong, 1997. Emerging Infect. Dis. 5 (1999), 195–203.
22. World Health Organization. Guidelines for the International Procurement of Vaccines and Sera, 1998, World Health Organization, Geneva.
23. Watts, J., G8 countries set priorities for infectious diseases but fail to make progress on debt relief. Bull. W. H. O., 78, 2000, 1168.